Ingrezza and Abdominal pain - a phase IV clinical study of FDA data

Summary:

Abdominal pain is reported as a side effect among people who take Ingrezza (valbenazine tosylate), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Seroquel, and have Tardive dyskinesia.

The phase IV clinical study analyzes which people have Abdominal pain when taking Ingrezza. It is created by eHealthMe based on reports of 23,655 people who have side effects when taking Ingrezza from the FDA, and is updated regularly.

What is Ingrezza?

Ingrezza has active ingredients of valbenazine tosylate. eHealthMe is studying from 23,666 Ingrezza users. Check the latest studies of Ingrezza.

What is Abdominal pain?

Abdominal pain is found to be associated with 3,217 drugs and 5,756 conditions by eHealthMe. Check the latest studies of Abdominal pain.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 04, 2026

23,655 people reported to have side effects when taking Ingrezza.
Among them, 32 people (0.14%) have Abdominal pain.

Among these 32 people:

How long have people been on Ingrezza when they have Abdominal pain? *

What is the gender of people who have Abdominal pain when taking Ingrezza? *

female: 90 %
male: 10 %

What is the age of people who have Abdominal pain when taking Ingrezza? *

What are other drugs people take besides Ingrezza? *

What are other side effects people have besides Abdominal pain? *

Nausea (feeling of having an urge to vomit): 8 people, 25.00%
Joint Pain: 7 people, 21.88%
Drowsiness: 6 people, 18.75%
Fatigue (feeling of tiredness): 5 people, 15.62%
Dizziness: 5 people, 15.62%
Dyspnea (difficult or laboured breathing): 4 people, 12.50%
Gait Disturbance: 4 people, 12.50%
Affective Disorder (mental disorder): 4 people, 12.50%
Insomnia (sleeplessness): 4 people, 12.50%
Stress And Anxiety: 4 people, 12.50%

What are the existing conditions these people have? *

Tardive Dyskinesia (a disorder that involves involuntary movements): 22 people, 68.75%
Quit Smoking: 3 people, 9.38%
Insomnia (sleeplessness): 2 people, 6.25%
Depression: 2 people, 6.25%
Sleep Disorder: 1 person, 3.12%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 3.12%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 3.12%
Extrapyramidal Disorder (involuntary muscle spasms in the face and neck): 1 person, 3.12%
Dyskinesia (abnormality or impairment of voluntary movement): 1 person, 3.12%
Drowsiness: 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Ingrezza and have Abdominal pain?

- Check whether Abdominal pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ingrezza:

Ingrezza (23,666 reports)

Abdominal pain treatments and more:

Abdominal pain (286,410 reports)

Browse all side effects of Ingrezza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal pain:

Abdominal pain (3,217 drugs)

Browse all the conditions that are associated with Abdominal pain:

Abdominal pain (5,756 conditions)

Related publications that referenced our studies

Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .

How the study uses the data?

The study uses data from the FDA. It is based on valbenazine tosylate (the active ingredients of Ingrezza) and Ingrezza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.